Molecular Classification in Patients With Endometrial Cancer After Fertility-Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence

The Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) is a molecular classification system that identifies endometrial cancer (EC) into four prognostically distinct subtypes: POLE-mutated, mismatch repair deficiency (MMR-D), p53 wild-type (p53wt), and p53 abnormal (p53abn). Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Xuting, Hu, Tingwenyi, Li, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160735/
https://www.ncbi.nlm.nih.gov/pubmed/35664732
http://dx.doi.org/10.3389/fonc.2022.810631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160735/
https://www.ncbi.nlm.nih.gov/pubmed/35664732
http://dx.doi.org/10.3389/fonc.2022.810631

Ejemplares similares